ARX-201

N/A

Report date: 2022/05/18 16:16:31

Base Information

Drug NameARX-201
Drug Alias NamePEGhGHPEG-human growth hormone variants30KPEG-N1-pAFhGH30PEG-N4-pAFhGHPEG-hGH +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonistsInsulin-like growth factor I receptor agonists
TargetsGrowth hormone receptorInsulin-like growth factor IInsulin-like growth factor I receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmbrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmbrx IncMerck Serono International Sa
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiency

Other Information

ATC CodeH01AC01
Related LinksN/A